Mirviss Jeffrey B.'s Form 4 filing
Boston Scientific Corp (BSX) · filed Feb 22, 2023
- Accession no.
- 0001225208-23-002532
- Filed
- Feb 22, 2023
- Trade date
- Feb 21-22, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $261.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mirviss Jeffrey B.CIK 0001566094 | Officer (EVP&Pres, Periph Intervent) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Common Stock | MOption exerciseAcquired | +2,804 | $0.00F1 | $0 | 95,411 | Direct | |
| Feb 21, 2023 | Common Stock | FTax withholdingDisposed | −1,279 | $46.23 | −$59,128.17 | 94,132 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −2,313 | $46.32 | −$107,138.16 | 91,819 | Direct | |
| Feb 22, 2023 | Common Stock | SSaleDisposed | −3,340 | $46.10 | −$153,974 | 88,479 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Common Stock | MOption exerciseDisposed | −2,804 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Referenced by the price of 1 transaction in Table I.